bisantrene has been researched along with Metastase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, G; Coltman, CA; Kuhn, J; Myers, JW; Pocelinko, R; Sandbach, JF; Von Hoff, DD | 1 |
| Forastiere, AA; Hughes, AK; Perry, MC; Wood, WC | 1 |
| Barnes, BC; Blumenschein, GR; Bodey, GP; Schell, FC; Yap, BS; Yap, HY | 1 |
| Ahmed, T; Harper, HD; Kemeny, NE; Michaelson, RA | 1 |
| Hahn, RG; Jones, AR; Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J | 1 |
| Cowan, JD; Gehan, E; Jones, SE; Rivkin, SE | 1 |
| Alberts, DS; Mackel, C; Meyskens, FL | 1 |
| Chang, MN; Ingle, JN; Long, HJ; Schutt, AJ | 1 |
| Blumenschein, GR; Buzdar, AU; Esparza, L; Holmes, FA; Hortobagyi, GN; Yap, HY | 1 |
| Cavalli, F; Clavel, M; Gerard, B; Rozencweig, M; ten Bokkel Huinink, W | 1 |
1 trial(s) available for bisantrene and Metastase
| Article | Year |
|---|---|
A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Blood Pressure; Breast Neoplasms; Drug Administration Schedule; Female; Heart; Humans; Middle Aged; Neoplasm Metastasis | 1986 |
9 other study(ies) available for bisantrene and Metastase
| Article | Year |
|---|---|
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).
Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1981 |
Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer. A cancer and leukemia group B study.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Hematopoietic Stem Cells; Humans; Middle Aged; Neoplasm Metastasis | 1984 |
Bisantrene, an active new drug in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis | 1983 |
Phase II trial of bisantrene in advanced colorectal carcinoma.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1983 |
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms | 1983 |
Phase II trial of bisantrene in patients with advanced sarcoma: a Southwest Oncology Group Study.
Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Humans; Hypotension; Leukocyte Count; Middle Aged; Neoplasm Metastasis; Platelet Count; Sarcoma | 1986 |
Phase II trial of bisantrene in patients with metastatic melanoma.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis | 1986 |
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer.
Topics: Adult; Aged; Anthracenes; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Metastasis | 1986 |
Phase II evaluation of bisantrene in metastatic breast cancer.
Topics: Anthracenes; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Neoplasm Metastasis; Phlebitis | 1985 |